USFDA approves drug for the treatment of Eczema

The expanded approval for Rinvoq follows significant delays amid concerns over safety of JAK inhibitors.

188
USFDA Approval
USFDA Approval

Last Updated on October 14, 2024 by The Health Master

The U.S. Food and Drug Administration (USFDA) approved drugs from AbbVie Inc. and Pfizer Inc. for treating eczema, a skin disease, the companies said on Friday.

AbbVie’s Rinvoq and Pfizer’s Cibinqo have been approved to treat moderate-to-severe atopic dermatitis, or eczema, in patients who do not respond to previous treatments or when use of other treatments is not recommended.

Rinvoq’s approval was expanded from rheumatoid arthritis to treat eczema for patients 12 years and older, while Cibinqo was approved for use in only adults.

Both the drugs belong to a class called JAK inhibitors, which block inflammation-causing enzymes known as Janus kinases and target a range of autoimmune diseases.

Both Pfizer and AbbVie cited risks of serious infections and cardiovascular events, among others.

The expanded approval for Rinvoq follows significant delays amid concerns over safety of JAK inhibitors.

Cibinqo had last year received approvals from the European and UK regulators.

The USFDA last month added its strictest warning to labels of JAK inhibitor drugs from Pfizer, Eli Lilly and AbbVie following a review of Pfizer’s Xeljanz, another JAK inhibitor.

The initial results from a trial showed an increased risk of serious heart-related problems and cancer in some patients being treated with the drug.

USFDA gives nod to Glenmark for Nasal Spray to treat allergic rhinitis

USFDA gives tentative nod to Alembic for Dronedarone tablets

USFDA gives nod to Alembic Pharma for Vortioxetine tablets

USFDA gives nod to Alembic for generic drug to treat Parkinson’s disease

USFDA gives nod to Alembic Pharma for Doxycycline Hyclate tablets

USFDA gives tentative nod to Zydus Cadila for Pimavanserin capsules

Kerala DCA writes to NPPA to bring Kidney drug under DPCO

Pharma firms to install PNG run boilers to improve Air quality

Full marketing approval sought from DCGI for Covaxin

USFDA gives nod to Glenmark for Nasal Spray to treat allergic..

Narcotic Control Bureau seizes Drugs worth Rs 30 lakh

Big Pharma Companies buying land in Hyderabad

Govt warns against overuse, misuse of COVID medicines

BIS notifies new standard for these Medical Devices

Latest Notifications: Medical Devices

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news